How many drugs treat Hypermagnesemia?

Drug Landscape tracks 3 marketed treatments for Hypermagnesemia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/hypermagnesemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Hypermagnesemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypermagnesemia (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hypermagnesemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	First approval
Phoslo	CALCIUM ACETATE	Fresenius Medcl Care	calcium acetate	1982-01-01
Calcium Gluceptate	calcium glucoheptonate	Abbott	calcium glucoheptonate	1972-01-01
Plegisol In Plastic Container	CALCIUM CHLORIDE	Pfizer	calcium chloride	1971-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 2 drugs in Hypermagnesemia
Abbott · 1 drug in Hypermagnesemia
Fresenius Medcl Care · 1 drug in Hypermagnesemia
Pfizer · 1 drug in Hypermagnesemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hypermagnesemia:

Cite this brief

Drug Landscape (2026). Hypermagnesemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hypermagnesemia. Accessed 2026-06-10.

Hypermagnesemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing